Age-related Macular Degeneration
📧 Sign up to get email alerts when something new happens for Age-related Macular Degeneration.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: Comparison of Cytokine Profiles in Aqueous Humor of Patients With Age Related Macular Degeneration (AMD) [NA]
The trial completed and reports on cytokine profiles in the aqueous humor of patients with age-related macular degeneration.
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: The Sahlgrenska Anti-VEGF Study [Phase 2]
Phase 2 clinical trial update on an anti-VEGF therapy for age-related macular degeneration; the study is currently active but not recruiting…
-
CLINICAL_TRIALS trial_result · 2025-11-14Clinical Trial Update: IAI Versus Sham as Prophylaxis Against Conversion to Neovascular AMD [Phase 2]
Phase 2 trial comparing IAI to sham prophylaxis to prevent conversion to neovascular Age-Related Macular Degeneration; results from the comp…
-
CLINICAL_TRIALS trial_result · 2025-10-24Clinical Trial Update: An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD [Phase 3]
An extension study evaluating the long-term safety and efficacy of pegcetacoplan (APL-2) in geographic atrophy due to age-related macular de…
-
CLINICAL_TRIALS trial_result · 2025-10-16Clinical Trial Update: Phase 2/3 Study of ALK-001 in Geographic Atrophy [Phase 2, Phase 3]
A Phase 2/3 study of ALK-001 in Geographic Atrophy has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-10-15Clinical Trial Update: Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration [Phase 1, Phase 2]
Update on the VOY-101 trial for advanced non-neovascular age-related macular degeneration (geographic atrophy), a Phase 1/Phase 2 study that…
-
CLINICAL_TRIALS trial_result · 2025-10-15Clinical Trial Update: Safety and Tolerability of RPE Stem Cell-derived RPE(RPESC-RPE) Transplantation in Patients With Dry Age-related Macular Degeneration (AMD) [Phase 1, Phase 2]
Phase 1/2 clinical trial to assess the safety and tolerability of RPESC-RPE transplantation in patients with dry age-related macular degener…
-
CLINICAL_TRIALS trial_result · 2025-10-14Clinical Trial Update: AREDS 2 Ancillary Spectral Domain Optical Coherence Tomography Study
Completed ancillary study to AREDS 2 using spectral-domain optical coherence tomography to evaluate imaging in age-related macular degenerat…
-
CLINICAL_TRIALS trial_result · 2025-10-03Clinical Trial Update: Prevalence and Determinants of Shoulder Girdle Musculoskeletal Complaints in Geriatric Patients With Diminished Vision
This completed clinical trial assesses how prevalent shoulder girdle musculoskeletal complaints are and what factors influence them in older…
-
CLINICAL_TRIALS trial_result · 2025-10-01Clinical Trial Update: The Moran AMD Genetic Testing Assessment Study [Phase 2]
Phase 2 study update on Moran AMD Genetic Testing Assessment, evaluating genetic testing and nutritional biomarkers in age-related macular d…
-
CLINICAL_TRIALS trial_result · 2025-09-26Clinical Trial Update: Functionally Validated Structural Endpoints for Early AMD
Completed clinical trial update reporting functionally validated structural endpoints for early age-related macular degeneration. The update…
-
CLINICAL_TRIALS trial_result · 2025-09-23Clinical Trial Update: Long Term Efficacy of Faricimab Using a Treat and Extend Regimen for Type 3 Macular Neovascularization [Phase 4]
Phase 4 study evaluating the long-term efficacy of faricimab using a treat-and-extend regimen for Type 3 macular neovascularization associat…
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: The Role of Loteprednol in Reducing Post-Intravitreal Injection Related Pain [NA]
A completed clinical trial evaluated whether loteprednol reduces post-intravitreal injection pain in age-related macular degeneration.
-
CLINICAL_TRIALS trial_result · 2025-09-17Clinical Trial Update: Evaluating the Safety and Preliminary Efficacy of EXG202 Gene Therapy for Neovascular AMD [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the safety and preliminary efficacy of EXG202 gene therapy for wet age-related macular degeneration. T…
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: Dose Ranging Study of Carbidopa-levodopa [Phase 2]
Phase 2 dose-ranging study of carbidopa-levodopa for age-related macular degeneration has completed. Results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: Carbidopa-levodopa in Neovascular AMD [Phase 2]
A Phase 2 trial evaluating carbidopa-levodopa for neovascular age-related macular degeneration has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: Microperimetry and Eye Progressing From Stage 3 to Stage 4 Age-related Macular Degeneration (AMD) [NA]
A completed clinical trial investigated using microperimetry to monitor progression from stage 3 to stage 4 age-related macular degeneration…
-
CLINICAL_TRIALS trial_result · 2025-09-11Clinical Trial Update: Adherence to Lifestyle Changes for Age-related Macular Degeneration [NA]
This completed clinical trial evaluated adherence to lifestyle changes for age-related macular degeneration.
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: A Study of Danicopan in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration [Phase 2]
A Phase 2 study of Danicopan for geographic atrophy due to age-related macular degeneration was terminated, and results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: CNV in AMD Analyzed by OCT Angiography Under IntravitreaL Eylea (COCTAEyl)
This completed trial evaluated choroidal neovascularization in age-related macular degeneration using OCT angiography in eyes treated with i…
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: Robotic Subretinal tPA Injection Study [NA]
This clinical trial update reports the completion of a robotic subretinal tissue plasminogen activator (tPA) injection study. It investigate…
-
CLINICAL_TRIALS trial_result · 2025-08-24Clinical Trial Update: FOCUS: A Phase I/II First in Human Study to Evaluate the Safety and Efficacy of GT005 Administered in Subjects With Dry AMD [Phase 1, Phase 2]
The FOCUS study (GT005) in dry age-related macular degeneration was terminated in Phase 1/2, and results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-08-21Clinical Trial Update: Retinal Fundus Flavoprotein Fluorescence in Age Related Macular Degeneration [NA]
A completed clinical trial evaluated retinal fundus flavoprotein fluorescence in age-related macular degeneration, including geographic atro…
-
CLINICAL_TRIALS trial_result · 2025-08-12Clinical Trial Update: EXPLORE: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005 [Phase 2]
The EXPLORE Phase II study evaluating two doses of GT005 for dry age-related macular degeneration was terminated. Results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-08-06Clinical Trial Update: Stereotactic Radiotherapy for Wet AMD (STAR) [Phase 3]
Phase 3 trial STAR evaluating stereotactic radiotherapy for neovascular (wet) age-related macular degeneration has completed.